EMS1 gene expression in primary breast cancer: Relationship to cyclin D1 and oestrogen receptor expression and patient survival

Oncogene

Volumn 17, Issue 8, 1998, Pages 1053-1059

  Hui, Rina ^a   Ball, Jonathon R ^a,b   Macmillan, R Douglas ^c   Kenny, Frances S ^c   Prall, Owen W J ^a   Campbell, Douglas H ^a   Cornish, Ann L ^a   McClelland, Richard A ^d   Daly, Roger J ^a   Forbes, John F ^b   Blamey, Roger W ^c   Musgrove, Elizabeth A ^a   Robertson, John F R ^c   Nicholson, Robert I ^d   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Breast cancer; Cyclin D1; EMS1; Prognosis

Indexed keywords

CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR; MESSENGER RNA;

AGE; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE;

EID: 7344254622     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202023     Document Type: Article

References (36)

1. Adnane J, Gaudray P, Simon MP, Simony-Lafontaine J, Jeanteur P and Theillet C. (1989). Oncogene, 4, 1389-1395.
2. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Bresciani F and Weisz A. (1996). Oncogene, 12, 2315-2324.
3. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M and Bartek J. (1994). Int. J. Cancer, 57, 353-361.
4. Bartkova J, Lukas J, Strauss M and Bartek J. (1995). Oncogene, 10, 775-778.
5. Berns E, Foekens J, van Staveren I, van Putten W, de Koning H, Portengen H and Klijn J. (1995). Gene, 159, 11-18.
6. Berns EM, Klijn JG, van Staveren IL, Portengen H, Noordegraaf E and Foekens JA. (1992). Eur. J. Cancer, 28, 697-700.
7. Borg A, Sigurdsson H, Clark GM, Ferno M, Fuqua SA, Olsson H, Killander D and McGurie WL. (1991). Br. J. Cancer, 63, 136-142.
8. Bringuier PP, Tamimi Y, Schuuring E and Schalken J. (1996). Oncogene, 12, 1747-1753.
9. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA and Sutherland RL. (1993). Oncogene, 8, 2127-2133.
10. Campbell DH, deFazio A, Sutherland RL and Daly RJ. (1996). Int. J. Cancer, 68, 485-492.
11. Fantl V, Richards MA, Smith R, Lammie GA, Johnstone G, Allen D, Gregory W, Peters G, Dickson C and Barnes DM. (1990). Eur. J. Cancer, 26, 423-429.
12. Fantl V, Smith R, Brookes S, Dickson C and Peters G. (1993). Cancer Surv., 18, 77-94.
13. Foster JS and Wimalasena J. (1996). Mol. Endocrin., 10, 488-498.
14. Gaffey MJ, Frierson Jr H and Williams ME. (1993). Mod. Path., 6, 654-659.
15. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D and Peters G. (1994). Cancer Res., 54, 1812-1817.
16. Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G and Barnes D. (1996). Int. J. Cancer, 69, 92-99.
17. Hui R, Campbell DH, Lee CSL, McCaul K, Horsfall DJ, Musgrove EA, Daly RJ, Seshadri R and Sutherland RL. (1997). Oncogene, 15, 1617-1623.
18. Hui R, Cornish AL, McClelland RA, Robertson JFR, Blamey RW, Musgrove EA, Nicholson RI and Sutherland RL. (1996). Clin. Cancer Res., 2, 923-928.
19. Karlseder J, Zeillinger R, Schneeberger C, Czerwenka K, Speiser P, Kubista E, Birnbaum D, Gaudray P and Theillet C. (1994). Genes Chromosom. Cancer, 9, 42-48.
20. Laborda J. (1991). Nucleic Acids Res., 19, 3998.
21. McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TW and Horne CH. (1995). Oncogene, 11, 885-891.
22. Michalides R, Hageman P, Vantinteren H, Houben L, Wientjens E, Klompmaker R and Peterse J. (1996). Br. J. Cancer, 73, 728-734.
23. Musgrove EA, Hamilton JA, Lee CS, Sweeney KJ, Watts CK and Sutherland RL. (1993). Mol. Cell Biol., 13, 3577-3587.
24. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M and Ewen ME. (1997). Mol. Cell. Biol., 17, 5338-5347.
25. Patel AM, Incognito LS, Schechter GL, Wasilenko WJ and Somers KD. (1996). Oncogene, 12, 31-35.
26. Pelosio P, Barbareschi M, Bonoldi E, Marchetti A, Verderio P, Caffo O, Bevilacqua P, Boracchi P, Buttitta F, Barbazza R, Dalla Palma P and Gasparini G. (1996). Ann. Oncology, 7, 695-703.
27. Peters G, Fantl V, Smith R, Brookes S and Dickson C. (1995). Breast Cancer Res. Treat., 33, 125-135.
28. Prall OWJ, Sarcevic B, Musgrove EA, Watts CKW and Sutherland RL. (1997). J. Biol. Chem., 272, 10882-10894.
29. Schuuring E. (1995). Gene, 159, 83-96.
30. Schuuring E, Verhoeven E, Litvinov S and Michalides RJ. (1993). Mol. Cell. Biol., 13, 2891-2898.
31. Schuuring E, Verhoeven E, Mooi WJ and Michalides RJ. (1992a) Oncogene, 7, 355-361.
32. Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FB, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ and Michalides RJ. (1992b) Cancer Res., 52, 5229-5234.
33. Seshadri R, Lee CSL, Hui R, McCaul K, Horsfall DJ and Sutherland RL. (1996). Clin. Cancer. Res., 2, 1177-1184.
34. van Damme H, Brok H, Schuuring-Scholtes E and Schuuring E. (1997). J. Biol. Chem., 272, 7374-7380.
35. van Diest PJ, Michalides RJ, Jannink L, van der Valk P, Peterse HL, de Jong JS, Meijer CJ and Baak JP. (1997). Am. J. Pathol., 150, 705-711.
36. Wu H, Reynolds AB, Kanner SB, Vines RR and Parsons JT. (1991). Mol. Cell. Biol., 11, 5113-5124.